Company Name:Gilead Sciences Inc.
CEO: Daniel O┬┐Day

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.


Key numbers

Market Capitalization:82323310500
Shares Outstanding: 1265150000
Float: 1258686348.6499999
Next Earning Date:2020-02-11
TTm EPS: 2.111
TTm Dividend Rate: 2.46
200 days moving average:65.32
50 days moving average: 64.59
One day percent Change: 2.76



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,